Seed VC · USA

Illumina Ventures

Active

What they invest in

Illumina Ventures is the leader in genomics and precision health investing, building the ecosystem and translating investment into innovation to accelerate impact on human health.

Who they back

DeepTechHealthtechBiotechFood & AgSeedSeries ASeries B+

Business models

saas_b2b, deeptech_ip, biotech_therapeutics, platform

Customer segments

Researchers, Enterprise, Healthcare Providers

Geography

US, Europe

Recent investments

  • NuCicer
  • Alamar Biosciences
  • Iambic Therapeutics

The people who write checks

12 partners on file at Illumina Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Illumina Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Illumina Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Oct 2017
Portfolio last checked
Oct 6, 2026
Website
www.illuminaventures.com ↗

Other firms investing in DeepTech

See all investors

Is Illumina Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Illumina Ventures is one of them, and we'll tell you exactly where they sit in your top 100.